Health Boards
›
Psoriasis In The News
Enbrel biosimilar candidate, SB4 accepted for review by European Medicines Agency
|
Enbrel biosimilar candidate, SB4 accepted for review by European Medicines Agency
|
 (Wed-28-01-2015, 22:10 PM)jiml Wrote: Nice to see biosimilars coming online although I doubt it will reduce the cost significantly immediately. But let's hope as Enbrel start to lose market share it may start a price war .... Well you never know No... that will not happen. They, the Pharma's, know and speak to each other. Unfortunately.  To Illustrate: Big Pharma 'overcharging' poor countries for child vaccines - report [web]https://rt.com/usa/224835-pharma-vaccine-expensive-poor/[/web] |
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Enbrel biosimilar candidate, SB4 accepted for review by European Medicines Agency - by Fred - Wed-28-01-2015, 17:14 PM
RE: Enbrel biosimilar candidate, SB4 accepted for review by European Medicines Agency - by jiml - Wed-28-01-2015, 22:10 PM
RE: Enbrel biosimilar candidate, SB4 accepted for review by European Medicines Agency - by Caroline - Wed-28-01-2015, 22:26 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Candidate biomarkers of disease progression in psoriasis | Fred | 3 | 2,532 |
Sat-21-05-2022, 21:30 PM Last Post: Fred |
|
|
Deucravacitinib accepted by FDA and validated by EMA | Fred | 6 | 4,605 |
Tue-30-11-2021, 16:14 PM Last Post: Caroline |
|
|
Enbrel producer to invest €145 million in Ireland | Fred | 1 | 4,948 |
Mon-04-11-2019, 16:18 PM Last Post: glenda grant |
|
|
Skilarence (DMF) gets European Commission approval | Fred | 26 | 26,043 |
Sat-01-07-2017, 07:33 AM Last Post: Caroline |
|
|
Enbrel, Humira & Stelara efficacy and adverse event study | Fred | 2 | 4,439 |
Tue-07-03-2017, 20:01 PM Last Post: mataribot |
